voriconazole has been researched along with Acute Liver Injury, Drug-Induced in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (12.50) | 29.6817 |
2010's | 28 (70.00) | 24.3611 |
2020's | 7 (17.50) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
DiNardo, CD; DiPippo, AJ; Jiang, Y; Kadia, T; Kontoyiannis, DP; Maiti, A; Montalban-Bravo, G; Rausch, CR; Ravandi, F | 1 |
Feng, Y; Hao, X; He, S; Hou, K; Hu, L; Huang, L; Shang, J; Yang, C; Zhang, Y | 1 |
Fujii, S; Hamada, Y; Hanai, Y; Kimura, T; Matsumoto, K; Mayumi, T; Miyazaki, Y; Oda, K; Takahashi, Y; Takesue, Y; Ueda, T | 1 |
Kuo, CH; Lin, SW; Su, KY; Wei, TY; Wu, SL | 1 |
Aram, JA; Freivogel, K; Lem, J; Lewis, A; Moosavi, S; Sobel, RE; Younus, M | 1 |
Chan, SY; Hughes, RM; Neofytos, D; Papanicolaou, G; Perales, MA; Woo, K | 1 |
Cheng, CN; Kuo, CH; Lin, SW; Wang, CC; Wu, SL | 1 |
Alharbi, AF; Fisher, J; Jacobson, PA; Kirstein, MN; Rubin, NT; Smith, AR; Takahashi, T | 1 |
Alshaya, OA; Alshehri, SD; Saleh, RA | 1 |
Anzawa, K; Mochizuki, T; Watanabe, S | 1 |
Chen, J; Hu, J; Liu, X; Su, H; Tong, J; Xiao, L; Yang, H; Zhang, L | 1 |
Girmenia, C; Goffredo, BM; Marchesi, F; Mengarelli, A; Menna, P; Minotti, G; Romano, A; Salvatorelli, E | 1 |
Bandín-Vilar, EJ; Blanco-Dorado, S; Fernández-Ferreiro, A; Ferrón Vidán, F; Lamas, MJ; Latorre-Pellicer, A; Maroñas Amigo, O; Marques Afonso, AT; Novo-Veleiro, I | 1 |
Hirata, A; Hosomi, K; Matsuoka, H; Noto, K; Ota, R; Takada, M; Yokoyama, S | 1 |
Kawakami, J; Mino, Y; Naito, T; Yamada, T | 1 |
Liu, P; Mould, DR | 1 |
Chen, GY; Chiu, HH; Kuo, CH; Lin, SW; Tsai, SJ; Tseng, YJ | 1 |
Chen, L; Cheng, X; Dong, H; Dong, Y; Sun, J; Wang, T; Wang, X; Xie, J; Xing, J; Zhu, H | 1 |
Dabó, H; Gomes, I; Marinho, A | 1 |
Cai, S; Chen, W; Li, Y; Liang, F; Liu, X; Meng, D; Rui, J; Xiao, X; Xie, H; Yin, X; Zhang, T | 1 |
Abematsu, K; Ikawa, K; Kanazawa, N; Matsumoto, K; Morikawa, N; Shigemi, A; Takeda, Y; Watanabe, E; Yokoyama, Y | 1 |
Ahn, KS; Hwang, JS; Jang, BK; Kang, KJ; Kang, YN; Kim, HT; Kim, IM; Kim, TS; Kim, YH | 1 |
Lopez, JL; Tayek, JA | 1 |
Dong, W; Dong, Y; Wang, T; Wang, X; Wang, Y; Xie, J; Xing, J; Yang, Q; Zheng, X | 1 |
Bonney, P; Crawford, D; Gallant, R; Peek, L; Yu, Z | 1 |
Amigues, I; Barker, J; Chung, D; Cohen, N; Jakubowski, A; Papanicolaou, GA; Plescia, C; Seo, SK | 1 |
Inoue, T; Kakita, T; Matsuda, H; Mori, T; Nagatoya, K; Teranishi, J; Yamauchi, Y | 1 |
Bedouch, P; Belaiche, S; Pison, C; Quetant, S; Roustit, M; Saint-Raymond, C | 1 |
Ieda, M; Kobayashi, D; Ohshima, S; Yamamoto, M | 1 |
Chen, Y; Groothuis, GM; Hadi, M; Merema, MT; Starokozhko, V | 1 |
Auzinger, G; Bernal, W; Heneghan, MA; López, JC; Solís-Muñoz, P; Verma, A; Wendon, J; Willars, C | 1 |
Brayshaw, N; Tan, K; Tomaszewski, K; Troke, P; Wood, N | 1 |
Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE | 1 |
Foo, H; Gottlieb, T | 1 |
den Hollander, JG; Levin, MD; Rijnders, BJ; Sonneveld, P; van der Holt, B; van Schaik, RH; van Vliet, M | 1 |
Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S | 1 |
4 review(s) available for voriconazole and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Impact of cytochrome P450 2C19 polymorphisms on the clinical efficacy and safety of voriconazole: an update systematic review and meta-analysis.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Genotype; Humans; Polymorphism, Genetic; Treatment Outcome; Voriconazole | 2022 |
Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Consensus; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; East Asian People; Humans; Voriconazole | 2022 |
Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature.
Topics: Adult; Antifungal Agents; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Dyslipidemias; Gastroesophageal Reflux; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Jaundice, Obstructive; Lansoprazole; Liver; Male; Polypharmacy; Proton Pump Inhibitors; Pulmonary Aspergillosis; Simvastatin; Voriconazole | 2016 |
3 trial(s) available for voriconazole and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Efficacy and safety of voriconazole and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Female; Fungemia; Humans; Male; Meningitis, Fungal; Middle Aged; Plasma; Polymorphism, Genetic; Treatment Outcome; Voriconazole; Young Adult | 2014 |
Population Pharmacokinetics in China: The Dynamics of Intravenous Voriconazole in Critically Ill Patients with Pulmonary Disease.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; China; Computer Simulation; Critical Illness; Female; Humans; Lung Diseases; Male; Middle Aged; Models, Biological; Monte Carlo Method; Voriconazole; Young Adult | 2015 |
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2002 |
33 other study(ies) available for voriconazole and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.
Topics: Adult; Antifungal Agents; Azoles; Chemical and Drug Induced Liver Injury; Echinocandins; Fungi; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Retrospective Studies; Triazoles; Voriconazole | 2022 |
Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice.
Topics: Animals; Antifungal Agents; Chemical and Drug Induced Liver Injury; Chromatography, Liquid; Liver; Male; Mass Spectrometry; Metabolome; Metabolomics; Mice, Inbred C57BL; Multivariate Analysis; Oxidative Stress; Voriconazole | 2019 |
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Checklist; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; European Union; Health Care Surveys; Health Personnel; Humans; Invasive Pulmonary Aspergillosis; Mycoses; Pamphlets; Pharmacovigilance; Risk Reduction Behavior; Self Report; Skin Neoplasms; Voriconazole | 2019 |
Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Chemical and Drug Induced Liver Injury; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Risk Factors; Transplant Recipients; Transplantation, Homologous; Treatment Outcome; Voriconazole | 2020 |
Metabolomics analysis of plasma reveals voriconazole-induced hepatotoxicity is associated with oxidative stress.
Topics: Aged; Antifungal Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Male; Metabolomics; Middle Aged; Oxidative Stress; Voriconazole | 2020 |
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Drug-Related Side Effects and Adverse Reactions; Hematopoietic Stem Cell Transplantation; Humans; Sterol 14-Demethylase; Voriconazole | 2021 |
Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection.
Topics: Adult; Amphotericin B; Antifungal Agents; Chemical and Drug Induced Liver Injury; COVID-19; Female; Fusarium; Humans; SARS-CoV-2; Sepsis; Voriconazole | 2021 |
Case of mycotic cyst caused by Scedosporium apiospermum developed liver dysfunction following administration of voriconazole.
Topics: Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cysts; Female; Humans; Mycoses; Scedosporium; Voriconazole | 2017 |
Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Drug Monitoring; Humans; Invasive Pulmonary Aspergillosis; Liver Failure; Male; Treatment Outcome; Voriconazole; Young Adult | 2017 |
Isavuconazole: Case Report and Pharmacokinetic Considerations.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bronchoalveolar Lavage Fluid; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Half-Life; Humans; Immunocompromised Host; Nitriles; Pyridines; Tandem Mass Spectrometry; Triazoles; Voriconazole; Young Adult | 2018 |
Voriconazole hepatotoxicity as a result of steroid withdrawal in a patient with allergic bronchopulmonary aspergillosis.
Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inducers; Drug Interactions; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Prednisone; Voriconazole; Withholding Treatment | 2019 |
Voriconazole trough concentration and hepatotoxicity in patients with low serum albumin
.
Topics: Aged; Antifungal Agents; Chemical and Drug Induced Liver Injury; Drug Monitoring; Female; Humans; Male; Middle Aged; Retrospective Studies; Serum Albumin, Human; Voriconazole | 2019 |
Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients.
Topics: Administration, Oral; Aged; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Immunocompromised Host; Incidence; Japan; Liver Function Tests; Male; Middle Aged; Mycoses; Oxygenases; Voriconazole | 2019 |
Population pharmacokinetic-pharmacodynamic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Chemical and Drug Induced Liver Injury; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Hallucinations; Humans; Male; Middle Aged; Models, Statistical; Photophobia; Prospective Studies; Voriconazole | 2014 |
Development and application of a comparative fatty acid analysis method to investigate voriconazole-induced hepatotoxicity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antifungal Agents; Biomarkers; Case-Control Studies; Chemical and Drug Induced Liver Injury; Fatty Acids; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Metabolomics; Mice; Mice, Inbred C57BL; Middle Aged; Voriconazole; Young Adult | 2015 |
Pulmonary Aspergillus Nodule--Still Challenging?
Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Chemical and Drug Induced Liver Injury; Chronic Disease; Diagnosis, Differential; Drug Resistance, Fungal; Drug Substitution; Female; Hemoptysis; Humans; Itraconazole; Lung Neoplasms; Middle Aged; Pulmonary Aspergillosis; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Voriconazole | 2015 |
Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Asian People; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Liver; Male; Middle Aged; Voriconazole; Young Adult | 2016 |
Successful Treatment of Combined Aspergillus and Cytomegalovirus Abscess in Brain and Lung After Liver Transplant for Toxic Fulminant Hepatitis.
Topics: Antifungal Agents; Biopsy; Brain Abscess; Chemical and Drug Induced Liver Injury; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Liver Transplantation; Lung Abscess; Magnetic Resonance Imaging; Middle Aged; Mushroom Poisoning; Neuroaspergillosis; Neurosurgical Procedures; Opportunistic Infections; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2017 |
Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Intensive Care Units; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Voriconazole | 2016 |
Voriconazole-induced hepatotoxicity following the administration of PEG-asparaginase: Case report.
Topics: Antifungal Agents; Antineoplastic Agents; Asparaginase; Aspergillosis; Chemical and Drug Induced Liver Injury; Child; Humans; Male; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole | 2017 |
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Cohort Studies; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver; Liver Function Tests; Lymphocyte Depletion; Male; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Statistics as Topic; T-Lymphocytes; Triazoles; Voriconazole | 2010 |
Voriconazole-associated salt-losing nephropathy.
Topics: Aged; Antifungal Agents; Biomarkers; Chemical and Drug Induced Liver Injury; Fluid Therapy; Humans; Hyponatremia; Kidney Diseases; Liver; Male; Neurophysins; Protein Precursors; Pyrimidines; Renin; Sodium; Sodium Chloride; Time Factors; Treatment Outcome; Triazoles; Vasopressins; Voriconazole; Water-Electrolyte Balance | 2010 |
Management of voriconazole hepatotoxicity in a lung transplant patient.
Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Transplantation; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Quantitative evaluation method of the informational value of initial symptoms based on Bayesian theory].
Topics: Antifungal Agents; Bayes Theorem; Chemical and Drug Induced Liver Injury; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Pharmacists; Probability; Pyrimidines; Symptom Assessment; Triazoles; Voriconazole | 2012 |
Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
Topics: Animals; Benzodiazepines; Biomarkers; Carbamazepine; Cell Survival; Chemical and Drug Induced Liver Injury; Chemokines; Chromans; Clozapine; Cytokines; Diclofenac; Drug Synergism; Female; Glutathione; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; In Vitro Techniques; Ketoconazole; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Nitrogen Oxides; Olanzapine; Pyrimidines; Thiazolidinediones; Triazoles; Troglitazone; Voriconazole | 2012 |
Voriconazole hepatotoxicity in severe liver dysfunction.
Topics: Adult; Aged; Amphotericin B; Analysis of Variance; Antifungal Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Observation; Pyrimidines; Triazoles; Voriconazole | 2013 |
Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.
Topics: Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver Function Tests; Male; Pyrimidines; Regression Analysis; Retrospective Studies; Risk Assessment; ROC Curve; Triazoles; Vision Disorders; Voriconazole | 2006 |
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole | 2006 |
Lack of cross-hepatotoxicity between voriconazole and posaconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chemical and Drug Induced Liver Injury; Humans; Pyrimidines; Triazoles; Voriconazole | 2007 |
Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Female; Genetic Predisposition to Disease; Humans; Injections, Intravenous; Liver; Male; Middle Aged; Polymorphism, Genetic; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |